Association of blood pressure with left ventricular mass in untreated hypertensives in rural yunnan province

American Journal of Hypertension

Volumn 22, Issue 7, 2009, Pages 730-734

  Akasheh, Ashkan ^a   Wu, Yangfeng ^b   Li, Yi ^c   Dustin, Laurie D ^d   Wong, Nathan D ^e   Gardin, Julius M ^f   Azen, Stanley P ^d   Detrano, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c Second People's Hospital of Yunnan Province   (China)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Touro College and University System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CHINA; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RURAL AREA;

AGED; BLOOD PRESSURE; CHINA; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RURAL POPULATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67649311830     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.75     Document Type: Article

References (22)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
2. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G, Reynolds RF, Su S, Whelton PK, He J. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002; 40:920-927.
3. Sun Z, Zheng L, Wei Y, Li J, Zhang X, Zhang X, Liu S, Xu C, Li J, Zhao F, Dong G, Hu D, Sun Y. The prevalence of prehypertension and hypertension among rural adults in Liaoning province of China. Clin Cardiol 2007; 30:183-187.
4. Sun Z, Zheng L, Detrano R, Zhang D, Zhang X, Xu C, Li J, Liu S, Li J, Hu D, Sun Y. The accelerating epidemic of hypertension among rural Chinese women: results from Liaoning Province. Am J Hypertens 2008; 21:784-788.
5. Wang Z, Wu Y, Zhao L, Li Y, Yang J, Zhou B. Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992-1998. Hypertens Res 2004; 27:703-709.
6. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
7. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998; 32:1454-1459.
8. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK. Major causes of death among men and women in China. N Engl J Med 2005; 353:1124-1134.
9. Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp RL, Sahn DJ, Schiller NB, Tajik A, Teichholz LE, Weyman AE. Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Twodimensional Echocardiography. Circulation 1980; 62:212-217.
10. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618.
11. Wang Y, Moss J, Thisted R. Predictors of body surface area. J Clin Anesth 1992; 4:4-10.
12. Chen D, Wu K, Xie L. [The prognostic characteristics of hypertensive left ventricular hypertrophy in a rural population]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1994; 16:29-34.
13. Devereux RB, Casale PN, Wallerson DC, Kligfield P, Hammond IW, Liebson PR, Campo E, Alonso DR, Laragh JH. Cost-effectiveness of echocardiography and electrocardiography for detection of left ventricular hypertrophy in patients with systemic hypertension. Hypertension 1987; 9:1169-1176.
14. Bleumink GS, Deinum J, Mosterd A, Witteman JC, Hofman A, Stricker BH. Antihypertensive treatment is associated with improved left ventricular geometry: the Rotterdam Study. Pharmacoepidemiol Drug Saf 2004; 13: 703-709.
15. Galderisi M, de Divitiis O. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 2008; 51:523-531.
16. Kjeldsen SE, Strand A, Julius S, Okin PM. Mechanism of angiotensin II type 1 receptor blocker action in the regression of left ventricular hypertrophy. J Clin Hypertens (Greenwich) 2006; 8:487-492.
17. Pierdomenico SD, Lapenna D, Cuccurullo F. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension. Am J Hypertens 2008; 21:464-470.
18. Salton CJ, Chuang ML, O'Donnell CJ, Kupka MJ, Larson MG, Kissinger KV, Edelman RR, Levy D, Manning WJ. Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol 2002; 39:1055-1060.
19. Gottdiener JS, Reda DJ, Materson BJ, Massie BM, Notargiacomo A, Hamburger RJ, Williams DW, Henderson WG. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am Coll Cardiol 1994; 24:1492-1498.
20. Gardin JM, Wagenknecht LE, Anton-Culver H, Flack J, Gidding S, Kurosaki T, Wng ND, Manolio TA. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation 1995; 92:380-387.
21. Gardin JM, Siscovick D, Anton-Culver H, Lynch JC, Smith VE, Klopfenstein HS, Bommer WJ, Fried L, O'Leary D, Manolio TA. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation 1995; 91:1739-1748.
22. Chan KW, Hu Y. Urbanization in China in the 1990s: new definition, different series, and revised trends. China Rev 2003; 3:49-71.